Li Yang

7.0k total citations
196 papers, 4.7k citations indexed

About

Li Yang is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Li Yang has authored 196 papers receiving a total of 4.7k indexed citations (citations by other indexed papers that have themselves been cited), including 104 papers in Molecular Biology, 71 papers in Cancer Research and 39 papers in Oncology. Recurrent topics in Li Yang's work include Cancer-related molecular mechanisms research (39 papers), RNA modifications and cancer (33 papers) and MicroRNA in disease regulation (31 papers). Li Yang is often cited by papers focused on Cancer-related molecular mechanisms research (39 papers), RNA modifications and cancer (33 papers) and MicroRNA in disease regulation (31 papers). Li Yang collaborates with scholars based in China, United States and Germany. Li Yang's co-authors include Zekuan Xu, Hao Xu, Haijuan Gu, Qingmin Sun, Rihong Cong, Naping Tang, Bo Zhou, Diancai Zhang, Yi Zhu and Xiang Ma and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and Blood.

In The Last Decade

Li Yang

189 papers receiving 4.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Li Yang China 38 3.0k 2.0k 754 508 452 196 4.7k
Changqian Wang China 34 3.0k 1.0× 2.0k 1.0× 499 0.7× 430 0.8× 480 1.1× 123 5.4k
Jie Ding China 34 2.3k 0.8× 1.7k 0.8× 506 0.7× 528 1.0× 401 0.9× 120 3.9k
Dawei Li China 36 2.7k 0.9× 1.5k 0.7× 884 1.2× 1.0k 2.0× 345 0.8× 130 4.6k
Xu Gao China 42 3.2k 1.1× 2.0k 1.0× 332 0.4× 340 0.7× 391 0.9× 146 4.9k
Yu Gan China 42 2.7k 0.9× 1.4k 0.7× 784 1.0× 711 1.4× 379 0.8× 176 5.2k
Qiang Wang China 41 4.9k 1.7× 3.0k 1.5× 657 0.9× 522 1.0× 552 1.2× 287 7.2k
Yue Zhang China 39 3.1k 1.1× 1.7k 0.9× 628 0.8× 518 1.0× 360 0.8× 200 5.0k
Peng Zhang China 30 2.0k 0.7× 1.1k 0.5× 443 0.6× 606 1.2× 306 0.7× 263 4.1k

Countries citing papers authored by Li Yang

Since Specialization
Citations

This map shows the geographic impact of Li Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Li Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Li Yang more than expected).

Fields of papers citing papers by Li Yang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Li Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Li Yang. The network helps show where Li Yang may publish in the future.

Co-authorship network of co-authors of Li Yang

This figure shows the co-authorship network connecting the top 25 collaborators of Li Yang. A scholar is included among the top collaborators of Li Yang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Li Yang. Li Yang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Huifang, Runhua Zhou, Chengchao Xu, et al.. (2025). GRP78 Nanobody‐Directed Immunotoxin Activates Innate Immunity Through STING Pathway to Synergize Tumor Immunotherapy. Advanced Science. 12(19). e2408086–e2408086. 1 indexed citations
2.
Yang, Li, et al.. (2024). Comparison of 3D and 2D laparoscopy: Initial experience of perioperative outcomes and clinical assessment. Journal of Gynecology Obstetrics and Human Reproduction. 53(4). 102754–102754.
3.
Xiao, Jian, Jiawei Wang, Pengyu Li, et al.. (2024). Leptin‐mediated suppression of lipoprotein lipase cleavage enhances lipid uptake and facilitates lymph node metastasis in gastric cancer. Cancer Communications. 44(8). 855–878. 10 indexed citations
5.
Willis, Brandon S., Hannah Dry, Wendan Xu, et al.. (2024). Potent combination benefit of the AKT inhibitor capivasertib and the BCL-2 inhibitor venetoclax in diffuse large B cell lymphoma. Leukemia. 38(12). 2663–2674. 2 indexed citations
7.
Tang, Yuting, Li Yang, Ying Meng, et al.. (2023). MiR-200b-5p inhibits tumor progression in salivary adenoid cystic carcinoma via targeting BTBD1. Cellular Signalling. 109. 110748–110748. 1 indexed citations
8.
Xiao, Jian, et al.. (2023). Prognostic Value of Tumor Size in Gastric Cancer: A Retrospective Cohort Study Based on SEER Database. International Journal of Surgical Pathology. 31(7). 1273–1282. 3 indexed citations
9.
Li, Ying, Yiwen Xia, Tianlu Jiang, et al.. (2023). Long noncoding RNA DIAPH2-AS1 promotes neural invasion of gastric cancer via stabilizing NSUN2 to enhance the m5C modification of NTN1. Cell Death and Disease. 14(4). 260–260. 31 indexed citations
10.
Xu, Hao, Weizhi Wang, Zhongyuan He, et al.. (2023). Evaluation of neoadjuvant immunotherapy plus chemotherapy in Chinese surgically resectable gastric cancer: a pilot study by meta-analysis. Frontiers in Immunology. 14. 1193614–1193614. 14 indexed citations
11.
Qian, Zhanyang, Pengfei Li, Li Yang, et al.. (2023). A Disintegrin and Metalloproteinase-8 Protects Against Erastin-Induced Neuronal Ferroptosis via Activating Nrf2/HO-1/FTH1 Signaling Pathway. Molecular Neurobiology. 61(6). 3490–3502. 9 indexed citations
12.
Fan, Hao, Yugang Ge, Xiang Ma, et al.. (2020). Long non-coding RNA CCDC144NL-AS1 sponges miR-143-3p and regulates MAP3K7 by acting as a competing endogenous RNA in gastric cancer. Cell Death and Disease. 11(7). 521–521. 36 indexed citations
13.
Li, Yu-Han, et al.. (2020). LncRNA SNHG5: A new budding star in human cancers. Gene. 749. 144724–144724. 50 indexed citations
14.
Shi, Liang, Chao Yang, Yugang Ge, et al.. (2019). miR-1254 inhibits cell proliferation, migration, and invasion by down-regulating Smurf1 in gastric cancer. Cell Death and Disease. 10(1). 32–32. 67 indexed citations
15.
Yang, Li, et al.. (2019). Early Stage Biomarkers Screening of Prostate Cancer Based on Weighted Gene Coexpression Network Analysis. DNA and Cell Biology. 38(5). 468–475. 1 indexed citations
16.
Zhang, Qiang, Jianghao Xu, Yi Qian, et al.. (2018). Association of Imatinib Plasma Concentration and Single-nucleotide Polymorphisms with Adverse Drug Reactions in Patients with Gastrointestinal Stromal Tumors. Molecular Cancer Therapeutics. 17(12). 2780–2787. 23 indexed citations
17.
Yang, Li, Zhengrong Li, Wenbin Zhang, et al.. (2018). Influence of body configuration on the therapeutic effects of totally laparoscopic and laparoscopy-assisted radical total gastrectomies: a multicentre retrospective study (A report of 677 cases). Zhōnghuá xiāohuà wàikē zázhì/Zhonghua xiaohua waike zazhi. 17(1). 60–67. 1 indexed citations
18.
Xu, Hao, Weizhi Wang, Panyuan Li, et al.. (2017). [The key points of prevention for special surgical complications after radical operation of gastric cancer].. PubMed. 20(2). 152–155. 1 indexed citations
19.
Pan, Minhong, et al.. (2014). [Interdigitating dendritic cell sarcoma/tumor: a clinicopathologic study].. PubMed. 43(2). 99–102. 3 indexed citations
20.
Wang, Dong, Enda Yu, Jihui Li, et al.. (2009). Laparoscopy-assisted trans-gastric endoscopic biopsy of retroperitoneal lymph node: a report of 1 case in human being. Zhonghua xiaohua neijing zazhi. 26(4). 171–174. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026